secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTIVION, INC. (AORT)
CIK:        0000784199
Form:       8-K
Filed at:   2026-02-12T23:59:59+00:00
Accession:  0001628280-26-007674
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artivion Q4 revenue $116M (+19%), GAAP net income $2.4M; full year $441M
------------------------------------------------------------------------

- GAAP revenue Q4 $116.0M vs $97.3M, net income $2.4M ($0.05 diluted EPS) vs net loss $16.5M in Q4 2024.
- Adjusted revenue (ex Italian reserve) $118.3M, up 18% constant currency; adjusted EBITDA $22.7M (+29%).
- Full year 2025 GAAP revenue $441.3M vs $388.5M; GAAP net income $9.8M vs loss $13.4M.
- Filed final PMA module for AMDS Hybrid Prosthesis with FDA; positive NEXUS TRIOMPHE clinical data at STS meeting.
- Non-GAAP net income Q4 $8.6M ($0.17 per share); full year $29.7M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/784199/000162828026007674/0001628280-26-007674-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/784199/000162828026007674/aort-20260212.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-007674

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer